United Therapeutics CorporationUTHRNASDAQ
LOADING
|||
PE Ratio: Premium Valuation
Trending higher, above historical average.
Left:
||||
Price-to-earnings ratio
Latest
13.34
↑ 64% above average
Average (9y)
8.12
Historical baseline
Range
High:20.39
Low:-36.92
CAGR
+2.1%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 13.34 | +27.7% |
| 2023 | 10.45 | -39.9% |
| 2022 | 17.40 | -14.7% |
| 2021 | 20.39 | +56.5% |
| 2020 | 13.03 | +135.3% |
| 2019 | -36.92 | -559.2% |
| 2018 | 8.04 | -48.4% |
| 2017 | 15.58 | +77.0% |
| 2016 | 8.80 | -20.4% |
| 2015 | 11.06 | - |